Mining Inc. (CA47009M8896)

Overview

Ecofibre Limited is a diversified company that operates across various sectors, including polymer technologies, health care, and hemp seed genetics, with its activities spread across the United States and Australia. Founded in 2009 and headquartered in Sydney, Australia, Ecofibre Limited showcases a comprehensive approach towards integrating hemp and cannabinoid-based solutions into a variety of applications ranging from health products to textiles. The company's operations are divided into four main segments: Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio, each focusing on distinct aspects of the company’s broad spectrum of offerings. Through these specialized segments, Ecofibre not only delves into traditional health and wellness products but also paves the way for innovative applications of hemp and cannabinoid technologies in both human and veterinary medicine, as well as in the development of advanced polymer and textile products.

Products and Services

• Cannabinoid Based Health Products

  Under its health-oriented brand, Ananda Health, Ecofibre offers a range of cannabinoid-based products aimed at enhancing the wellness of humans and pets. These products are designed to leverage the therapeutic properties of cannabinoids to address a variety of health issues and improve overall well-being.

• Yarn and Polymer Textiles

  Within the Ecofibre Advanced Technologies segment, the company utilizes its innovative approach to develop and market yarn and polymer textiles infused with hemp. These products stand out in the marketplace for their unique combination of durability, sustainability, and utility, catering to a wide array of industrial and consumer applications.

• Hemp Related Food Products

  Ecofibre also ventures into the food industry by developing and selling food products that incorporate hemp as a key ingredient. These offerings underscore the nutritional benefits of hemp seeds, including high levels of protein, omega fatty acids, and fiber, thus providing health-conscious consumers with beneficial and innovative dietary options.

• Patient-Centered Cannabinoid-Based Drug Activities

  Through the EOF Bio segment, Ecofibre is involved in the research and development of cannabinoid-based pharmaceuticals. These patient-centered activities aim at creating drugs that can effectively manage and treat various medical conditions by harnessing the medicinal properties of cannabinoids.